Annual CFI
$39.13 M
+$242.47 M+119.25%
31 December 2023
Summary:
Poseida Therapeutics annual cash flow from investing activities is currently $39.13 million, with the most recent change of +$242.47 million (+119.25%) on 31 December 2023. During the last 3 years, it has risen by +$243.56 million (+119.14%). PSTX annual CFI is now -82.40% below its all-time high of $222.38 million, reached on 31 December 2021.PSTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$27.65 M
+$88.85 M+145.17%
30 September 2024
Summary:
Poseida Therapeutics quarterly cash flow from investing activities is currently $27.65 million, with the most recent change of +$88.85 million (+145.17%) on 30 September 2024. Over the past year, it has increased by +$74.88 million (+158.53%). PSTX quarterly CFI is now -77.80% below its all-time high of $124.53 million, reached on 31 March 2021.PSTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$38.16 M
+$74.88 M+203.92%
30 September 2024
Summary:
Poseida Therapeutics TTM cash flow from investing activities is currently $38.16 million, with the most recent change of +$74.88 million (+203.92%) on 30 September 2024. Over the past year, it has increased by +$132.63 million (+140.40%). PSTX TTM CFI is now -85.90% below its all-time high of $270.55 million, reached on 30 September 2021.PSTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +119.3% | +158.5% | +140.4% |
| 3 y3 years | +119.1% | -25.6% | -85.9% |
| 5 y5 years | +3147.8% | +186.0% | +172.3% |
PSTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.4% | +119.1% | -42.1% | +132.2% | -85.9% | +118.4% |
| 5 y | 5 years | -82.4% | +119.1% | -77.8% | +110.7% | -85.9% | +115.8% |
| alltime | all time | -82.4% | +119.1% | -77.8% | +110.7% | -85.9% | +115.8% |
Poseida Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $27.65 M(-145.2%) | $38.16 M(-203.9%) |
| June 2024 | - | -$61.20 M(-355.0%) | -$36.72 M(-154.4%) |
| Mar 2024 | - | $24.00 M(-49.7%) | $67.55 M(+72.6%) |
| Dec 2023 | $39.13 M(-119.2%) | $47.71 M(-201.0%) | $39.13 M(-141.4%) |
| Sept 2023 | - | -$47.24 M(-209.7%) | -$94.47 M(+13.7%) |
| June 2023 | - | $43.07 M(-1075.6%) | -$83.10 M(-59.9%) |
| Mar 2023 | - | -$4.42 M(-94.9%) | -$207.01 M(+1.8%) |
| Dec 2022 | -$203.33 M(-191.4%) | -$85.89 M(+139.4%) | -$203.33 M(+72.8%) |
| Sept 2022 | - | -$35.87 M(-55.6%) | -$117.64 M(+163.6%) |
| June 2022 | - | -$80.83 M(>+9900.0%) | -$44.63 M(-146.0%) |
| Mar 2022 | - | -$743.00 K(+281.0%) | $97.12 M(-56.3%) |
| Dec 2021 | $222.38 M | -$195.00 K(-100.5%) | $222.38 M(-17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $37.13 M(-39.0%) | $270.55 M(-1197.7%) |
| June 2021 | - | $60.92 M(-51.1%) | -$24.65 M(-66.7%) |
| Mar 2021 | - | $124.53 M(+159.6%) | -$73.93 M(-63.8%) |
| Dec 2020 | -$204.43 M(+381.4%) | $47.97 M(-118.6%) | -$204.43 M(-15.6%) |
| Sept 2020 | - | -$258.06 M(-2318.2%) | -$242.10 M(+1394.5%) |
| June 2020 | - | $11.63 M(-294.8%) | -$16.20 M(-66.4%) |
| Mar 2020 | - | -$5.97 M(-158.0%) | -$48.17 M(+13.4%) |
| Dec 2019 | -$42.46 M(+3207.2%) | $10.30 M(-132.0%) | -$42.46 M(-19.5%) |
| Sept 2019 | - | -$32.16 M(+58.1%) | -$52.77 M(+156.1%) |
| June 2019 | - | -$20.34 M(+7545.9%) | -$20.60 M(+7645.9%) |
| Mar 2019 | - | -$266.00 K | -$266.00 K |
| Dec 2018 | -$1.28 M(+538.8%) | - | - |
| Dec 2017 | -$201.00 K | - | - |
FAQ
- What is Poseida Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Poseida Therapeutics?
- What is Poseida Therapeutics annual CFI year-on-year change?
- What is Poseida Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly CFI year-on-year change?
- What is Poseida Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Poseida Therapeutics?
- What is Poseida Therapeutics TTM CFI year-on-year change?
What is Poseida Therapeutics annual cash flow from investing activities?
The current annual CFI of PSTX is $39.13 M
What is the all time high annual CFI for Poseida Therapeutics?
Poseida Therapeutics all-time high annual cash flow from investing activities is $222.38 M
What is Poseida Therapeutics annual CFI year-on-year change?
Over the past year, PSTX annual cash flow from investing activities has changed by +$242.47 M (+119.25%)
What is Poseida Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PSTX is $27.65 M
What is the all time high quarterly CFI for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly cash flow from investing activities is $124.53 M
What is Poseida Therapeutics quarterly CFI year-on-year change?
Over the past year, PSTX quarterly cash flow from investing activities has changed by +$74.88 M (+158.53%)
What is Poseida Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PSTX is $38.16 M
What is the all time high TTM CFI for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM cash flow from investing activities is $270.55 M
What is Poseida Therapeutics TTM CFI year-on-year change?
Over the past year, PSTX TTM cash flow from investing activities has changed by +$132.63 M (+140.40%)